Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A 30 Year Partnership with Agar Scientific

Published: Friday, May 16, 2014
Last Updated: Friday, May 16, 2014
Bookmark and Share
Long-standing relationship helps Dr Young throughout a research career spanning rheumatoid arthritis, ocular degeneration.

A long-standing relationship with Agar Scientific has helped Dr Robert Young, currently working in the Cardiff Centre for Vision Science, throughout a research career spanning rheumatoid arthritis, ocular degeneration, osteoarthritis and corneal structure.

Use of microscopy has been at the heart of this work - covering various light microscopy techniques, transmission electron microscopy and 3D microscopy - and close ties with Agar have played a vital role, as Dr Young explained: “My first research lab had very close links with Alan Agar, the Company’s original founder. Alan used to come to the lab quite frequently, and we often got to test new products before launch. We were using various light microscopy and transmission electron microscopy techniques for our investigations, so were extremely fortunate to have those very close links with Alan, as well as later with Fred Sheldon and Lynne Joyce.”

“Although I have moved institutes several times, and the nature of my research has changed, I still acquire most of my microscopy supplies from Agar. I have worked with many other microscopists over the years - particularly in Bristol where I was part of an internationally renowned research group at the forefront of cryomicroscopy - and many of my colleagues also use Agar in preference to other microscopy suppliers, due to the Company’s friendly and personable approach. The Agar team has always offered useful advice, which is why I have enjoyed a good relationship with them for over 30 years.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!